Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-28

Clinical Trial Update: Polidocanol Versus Glucose Treatment of Telangiectasia Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing polidocanol versus glucose for treatment of telangiectasia in Varicose Veins completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucose (glucose)
  • polidocanol (polidocanol)

Snippet

Sponsor: UPECLIN HC FM Botucatu Unesp | Conditions: Varicose Veins, Telangiectasis | Phase 4 | Status: COMPLETED | Results posted: 2017-11-28